☰

Canan Nebigil - Publications

Affiliations: 
Duke University, Durham, NC 
Tree Info Grants Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Vincenzi M, Kremic A, Jouve A, Lattanzi R, Miele R, Benharouga M, Alfaidy-Benharouga N, Migrenne-Li S, Kanthasamy AG, Porcionatto M, Ferrara N, Tetko IV, Désaubry L, Nebigil CG. . Pharmacological Reviews. PMID 37684054 DOI: 10.1124/pharmrev.122.000801  0.314
2021 Demir F, Urayama K, Audebrand A, Toprak-Semiz A, Steenman M, Kurose H, Nebigil CG. Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies. Hypertension (Dallas, Tex. : 1979). 77: 1559-1570. PMID 33677981 DOI: 10.1161/HYPERTENSIONAHA.120.16808  0.559
2019 Gasser A, Chen YW, Audebrand A, Daglayan A, Charavin M, Escoubet B, Karpov P, Tetko I, Chan MWY, Cardinale D, Désaubry L, Nebigil CG. Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection. Jacc. Cardiooncology. 1: 84-102. PMID 34396166 DOI: 10.1016/j.jaccao.2019.06.003  0.47
2019 Nebigil CG, Désaubry L. The role of GPCR signaling in cardiac Epithelial to Mesenchymal Transformation (EMT). Trends in Cardiovascular Medicine. 29: 200-204. PMID 30172578 DOI: 10.1016/j.tcm.2018.08.007  0.399
2019 Gasser A, Chen Y, Audebrand A, Daglayan A, Charavin M, Escoubet B, Karpov P, Tetko I, Chan MW, Cardinale D, Désaubry L, Nebigil CG. Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection Jacc: Cardiooncology. 1: 84-102. DOI: 10.1016/j.jaccao.2019.06.003  0.368
2018 Qureshi R, Kindo M, Boulberdaa M, von Hunolstein JJ, Steenman M, Nebigil CG. A prokineticin-driven epigenetic switch regulates human epicardial cell stemness and fate. Stem Cells (Dayton, Ohio). PMID 29873146 DOI: 10.1002/stem.2866  0.315
2017 Qureshi R, Kindo M, Arora H, Boulberdaa M, Steenman M, Nebigil CG. Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21(+) fibroblast progenitor cell transformation into adipocytes and vascular cells. Scientific Reports. 7: 12804. PMID 29038558 DOI: 10.1038/s41598-017-13198-2  0.386
2016 Arora H, Boulberdaa M, Qureshi R, Bitirim V, Gasser A, Messaddeq N, Dolle P, Nebigil CG. Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development. Scientific Reports. 6: 25541. PMID 27150455 DOI: 10.1038/srep25541  0.385
2015 Gasser A, Brogi S, Urayama K, Nishi T, Kurose H, Tafi A, Ribeiro N, Désaubry L, Nebigil CG. Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1. Plos One. 10: e0121027. PMID 25831128 DOI: 10.1371/journal.pone.0121027  0.612
2015 Désaubry L, Zhao Q, Basmadjian C, Thuaud F, Ribeiro N, Nebigil C, Eggermont A, Robert C, Vagner S. P5.02Development of Novel Anticancer Agents that Target Prohibitins and the Translation Initiation Factor eIF4A Annals of Oncology. 26. DOI: 10.1093/Annonc/Mdv094.2  0.347
2014 Gasser A, Nishi T, Nguyen TL, Urayama K, Kurose H, Charavin M, Brogi S, Tafi A, Desaubry L, Nebigil C. 0365: Non-peptidic prokineticin receptor 1 agonist as a novel cardioprotective therapeutic Archives of Cardiovascular Diseases Supplements. 6: 21-22. DOI: 10.1016/S1878-6480(14)71323-0  0.614
2014 Nguyen TL, Boulberdaa M, Urayama K, Bitirim V, Geny B, Ruiz-Lozano P, Nebigil C. 0369: Proepicardial prokineticin receptor –1 (PKR1) as a developmental link between heart and kidney Archives of Cardiovascular Diseases Supplements. 6: 21. DOI: 10.1016/S1878-6480(14)71321-7  0.439
2013 Nguyen TL, Gasser A, Nebigil CG. Role of Prokineticin Receptor-1 in Epicardial Progenitor Cells. Journal of Developmental Biology. 1: 20-31. PMID 33374490 DOI: 10.3390/jdb1010020  0.515
2011 Boulberdaa M, Urayama K, Nebigil CG. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions Cardiovascular Research. 92: 191-198. PMID 21856786 DOI: 10.1093/cvr/cvr228  0.48
2011 Boulberdaa M, Turkeri G, Urayama K, Dormishian M, Szatkowski C, Zimmer L, Messaddeq N, Laugel V, Dollé P, Nebigil CG. Genetic inactivation of prokineticin receptor-1 leads to heart and kidney disorders. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 842-50. PMID 21273561 DOI: 10.1161/ATVBAHA.110.222323  0.391
2010 Guilini C, Urayama K, Turkeri G, Dedeoglu DB, Kurose H, Messaddeq N, Nebigil CG. Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration. American Journal of Physiology. Heart and Circulatory Physiology. 298: H844-52. PMID 20023120 DOI: 10.1152/ajpheart.00898.2009  0.576
2009 Nebigil CG. Prokineticin receptors in cardiovascular function: foe or friend? Trends in Cardiovascular Medicine. 19: 55-60. PMID 19577713 DOI: 10.1016/j.tcm.2009.04.007  0.517
2009 Urayama K, Dedeoglu DB, Guilini C, Frantz S, Ertl G, Messaddeq N, Nebigil CG. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage Cardiovascular Research. 81: 28-37. PMID 18806277 DOI: 10.1093/cvr/cvn251  0.48
2008 Urayama K, Guilini C, Turkeri G, Takir S, Kurose H, Messaddeq N, Dierich A, Nebigil CG. Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 841-9. PMID 18421008 DOI: 10.1161/ATVBAHA.108.162404  0.611
2007 Urayama K, Guilini C, Messaddeq N, Hu K, Steenman M, Kurose H, Ert G, Nebigil CG. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 2980-93. PMID 17442730 DOI: 10.1096/fj.07-8116com  0.617
2004 Jaffré F, Callebert J, Sarre A, Etienne N, Nebigil CG, Launay JM, Maroteaux L, Monassier L. Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. Circulation. 110: 969-74. PMID 15302781 DOI: 10.1161/01.CIR.0000139856.20505.57  0.403
2003 Nebigil CG, Maroteaux L. Functional consequence of serotonin/5-HT2B receptor signaling in heart: role of mitochondria in transition between hypertrophy and heart failure? Circulation. 108: 902-8. PMID 12925446 DOI: 10.1161/01.CIR.0000081520.25714.D9  0.37
2003 Nebigil CG, Jaffré F, Messaddeq N, Hickel P, Monassier L, Launay JM, Maroteaux L. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation. 107: 3223-9. PMID 12810613 DOI: 10.1161/01.CIR.0000074224.57016.01  0.461
2003 Nebigil CG, Etienne N, Messaddeq N, Maroteaux L. Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1373-5. PMID 12738797 DOI: 10.1096/fj.02-1122fje  0.408
2001 Nebigil CG, Maroteaux L. A novel role for serotonin in heart. Trends in Cardiovascular Medicine. 11: 329-35. PMID 11728882 DOI: 10.1016/S1050-1738(01)00135-9  0.338
2001 Nebigil CG, Hickel P, Messaddeq N, Vonesch JL, Douchet MP, Monassier L, György K, Matz R, Andriantsitohaina R, Manivet P, Launay JM, Maroteaux L. Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function. Circulation. 103: 2973-9. PMID 11413089 DOI: 10.1161/01.cir.103.24.2973  0.383
2001 Nebigil CG, Etienne N, Schaerlinger B, Hickel P, Launay JM, Maroteaux L. Developmentally regulated serotonin 5-HT2B receptors. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 19: 365-72. PMID 11378296 DOI: 10.1016/S0736-5748(01)00022-3  0.417
2000 Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay JM, Maroteaux L. Serotonin 2B receptor is required for heart development. Proceedings of the National Academy of Sciences of the United States of America. 97: 9508-13. PMID 10944220 DOI: 10.1073/PNAS.97.17.9508  0.405
2000 Manivet P, Mouillet-Richard S, Callebert J, Nebigil CG, Maroteaux L, Hosoda S, Kellermann O, Launay JM. PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor. The Journal of Biological Chemistry. 275: 9324-31. PMID 10734074 DOI: 10.1074/JBC.275.13.9324  0.362
1995 Nebigil CG, Garnovskaya MN, Spurney RF, Raymond JR. Identification of a rat glomerular mesangial cell mitogenic 5-HT2A receptor American Journal of Physiology-Renal Physiology. 268. PMID 7840237 DOI: 10.1152/Ajprenal.1995.268.1.F122  0.524
1995 Nebigil CG, Garnovskaya MN, Casañas SJ, Mulheron JG, Parker EM, Gettys TW, Raymond JR. Agonist-induced desensitization and phosphorylation of human 5-HT1A receptor expressed in Sf9 insect cells. Biochemistry. 34: 11954-62. PMID 7547932 DOI: 10.1021/BI00037A037  0.391
Show low-probability matches.